24/07/2014
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers prove the effectiveness of a new drug against malaria using synchrotron light
Researchers from the Universitat Politècnica de Catalunya - BarcelonaTech (UPC), the Institute of Medical Chemistry (IQM-CSIC) and the University of Glasgow have proved that the CD27 drug is a true alternative against malaria. They have analysed the crystalline structure of the DNA with the drug by performing X-ray diffraction experiments at the ALBA Synchrotron. This work has been published in the journal Acta Crystallographica D.
Read the full press release published by the ALBA Synchrotron
Read the full press release published by the ALBA Synchrotron
More news
21/03/2017
Barcelona Synchrotron Park Sponsors the Sixth Ideas Generation Program
16/03/2017
A new class of inhibitors against pain investigated at the ALBA synchrotron
07/03/2017
Building a University Residence in the Barcelona Synchrotron Park
01/03/2017
How Biodiversity is Supported in the Barcelona Synchrotron Park
23/02/2017
A Superconducting Electrical Generator in ICMAB
15/02/2017
Catalonia, a Gateway for China in Europe